Researchers at Carnegie Mellon University have
developed a method for self-assembling nanostructures with
gamma-modified peptide nucleic acid (γPNA), a synthetic mimic of
DNA. The process has the potential to impact nanomanufacturing as
well as future biomedical technologies like targeted diagnostics
and drug delivery.